Abstract

You have accessJournal of UrologyGeneral & Epidemiological Trends & Socioeconomics: Quality of Life1 Apr 2015MP27-04 A PSYCHOMETRIC ANALYSIS OF PAIN AND URINARY SYMPTOMS IN PATIENTS WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME AND CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME: FINDINGS FROM MAPP RESEARCH NETWORK James Griffith, Todd Edwards, Barry Hong, Siobhan Sutcliffe, Michel Pontari, Niloofar Afari, John Krieger, Robert Lloyd, Frank Tu, David Williams, Donald Patrick, Jayoung Kim, Bruce Naliboff, Henry Lai, Catherine Bradley, Chris Mullins, and Richard Landis James GriffithJames Griffith More articles by this author , Todd EdwardsTodd Edwards More articles by this author , Barry HongBarry Hong More articles by this author , Siobhan SutcliffeSiobhan Sutcliffe More articles by this author , Michel PontariMichel Pontari More articles by this author , Niloofar AfariNiloofar Afari More articles by this author , John KriegerJohn Krieger More articles by this author , Robert LloydRobert Lloyd More articles by this author , Frank TuFrank Tu More articles by this author , David WilliamsDavid Williams More articles by this author , Donald PatrickDonald Patrick More articles by this author , Jayoung KimJayoung Kim More articles by this author , Bruce NaliboffBruce Naliboff More articles by this author , Henry LaiHenry Lai More articles by this author , Catherine BradleyCatherine Bradley More articles by this author , Chris MullinsChris Mullins More articles by this author , and Richard LandisRichard Landis More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.1166AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Approaches are needed to better characterize the course of interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), conditions which are collectively referred to as urologic chronic pelvic pain syndromes (UCPPS). As part of a prospective observational study within the Multi-Disciplinary Assessment of Pelvic Pain (MAPP) Research Network, patients diagnosed with IC/BPS and CP/CPPS completed a battery of questionnaires. The purpose of this research was to examine the number of factors among a large set questionnaire items, which helps to understand the symptom structure of pelvic pain, as well as to create simple indices to characterize changes in symptoms. METHODS MAPP participants (N = 424) completed a battery of baseline questionnaires, including the American Urological Association Symptom Index (AUA-SI), the Interstitial Cystitis Symptom Index and Problem Index (ICSI, ICPI), the Genitourinary Pain Index (GUPI), and symptom scales developed specifically for the MAPP. These questionnaire items were examined with exploratory factor analyses. RESULTS Using items from the ICSI, ICPI, and GUPI, two factors accounted for 56% of the variance and provided a good fit to this set of questionnaire items. These factors were rotated using an oblique rotation, which allows the factors to be correlated. These two factors represented pelvic pain symptoms versus urinary symptoms, which were correlated, r =.5. Based on these factor analysis results and further elimination of redundant items (the four items from the ICPI), we created two simple indices: 1) The GUPI pain scale + the ICSI bladder pain question, and 2) The GUPI urinary scale + the 3 ICSI questions about urinary symptoms. These two scales recapitulated most of the variance found in the two factors (r's >=.92). These two indices were then explored with regard to other variables of interest. For example, depression was measured by the Hospital Anxiety and Depression Scale was predicted by pain (β =.3, p <.001), but not by urinary symptoms (β <.1, ns) in a simultaneous regression. CONCLUSIONS UCPPS can be measured using two simple indices. Two meaningful factors are evident (pain versus urinary symptoms), and these two factors show differential relationships with important comorbidities, such as depression. Future analyses within MAPP will characterize symptom changes over time and study their relationship with other comorbid symptoms and biomarkers. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e303 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information James Griffith More articles by this author Todd Edwards More articles by this author Barry Hong More articles by this author Siobhan Sutcliffe More articles by this author Michel Pontari More articles by this author Niloofar Afari More articles by this author John Krieger More articles by this author Robert Lloyd More articles by this author Frank Tu More articles by this author David Williams More articles by this author Donald Patrick More articles by this author Jayoung Kim More articles by this author Bruce Naliboff More articles by this author Henry Lai More articles by this author Catherine Bradley More articles by this author Chris Mullins More articles by this author Richard Landis More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.